![David MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David MacDonald currently works at XORTX Therapeutics, Inc., as Chief Technology Officer from 2022.
Dr. MacDonald also formerly worked at Active Pass Pharmaceuticals, Inc., as President & Chief Executive Officer, MSI Methylation Sciences, Inc., as Chief Technology Officer & Vice President from 2008 to 2017, Hemosol Corp., as Section Leader, Syntex, Inc., as Staff Researcher, Biovail Contract Research Division, as General Manager, and Immunoflex Therapeutics, Inc., as Chief Technology Officer from 2020 to 2021.
Dr. MacDonald received his doctorate degree from the University of Alberta.
| Unternehmen | Position | Beginn |
|---|---|---|
| XORTX THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.01.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Immunoflex Therapeutics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Biovail Contract Research Division
 Biovail Contract Research Division Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Corporate Officer/Principal | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Syntex, Inc.
 Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 8 |
|---|---|
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Health Technology |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Pass Pharmaceuticals, Inc.
 Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Health Technology |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Biovail Contract Research Division
Biovail Contract Research Division Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Commercial Services |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Immunoflex Therapeutics, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
